. "3" . "Therapy problems of porcine pleuropneumonia"@en . "RIV/00027162:_____/09:#0000513!RIV10-MZE-00027162" . "0027-8068" . . "3"^^ . . "69" . . "3"^^ . "Therapy problems of porcine pleuropneumonia"@en . . . "Jagli\u010D, Zoran" . "Problematika terapie aktinobacilov\u00E9 pleuropneumonie prasat"@cs . "[617B0438CB44]" . . "N\u00E1\u0161 chov" . . . "P(QH71051), Z(MZE0002716202)" . "Problematika terapie aktinobacilov\u00E9 pleuropneumonie prasat" . . . "CZ - \u010Cesk\u00E1 republika" . . "Problematika terapie aktinobacilov\u00E9 pleuropneumonie prasat"@cs . "Actinobacillus pleuropneumoniae; resistance; antimicrobial agents; pigs"@en . "Low level immunity of pigs, poor hygiene in breeding and resistance Actinobacillus pleuropneumoniae to antimicrobial agents are factors that complicated antimicrobial therapy of porcine pleuropneumonia. Quantitative level of resistance to antimicrobial agents was determined by broth microdilution method in 82 A. pleuropneumoniae isolates which were collected in year 2008 from 70 pig herds. Amoxicillin/clavulanic acid, tiamulin, co-trimoxazole folowed to antimicrobial agents which the prescription is restricted to specific indications, cefchinom and enrofloxacin were complete sensitive. Low level of prevalence resistant isolates (1.2 %) was detected in amoxicillin, tilmicosin, florfenicol and flumequine. The highest level of prevalence resistant isolates (20.7 %) was found to tetracycline."@en . "Problematika terapie aktinobacilov\u00E9 pleuropneumonie prasat" . "Nedbalcov\u00E1, Kate\u0159ina" . . "RIV/00027162:_____/09:#0000513" . . . "Efektivn\u00ED terapie aktinobacilov\u00E9 pleuropneumoniae antibiotiky je komplikov\u00E1na n\u00EDzkou \u00FArovn\u00ED imunity prasat, neuspokojivou \u00FArovn\u00ED zoohygieny a rezistenc\u00ED A. pleuropneumoniae k antibiotik\u016Fm. Kvantitativn\u00ED \u00FArove\u0148 rezistence A. pleuropneumoniae k antibiotik\u016Fm byla v roce 2008 vy\u0161et\u0159ena dilu\u010Dn\u00ED mikrometodou celkem u 82 izol\u00E1t\u016F, kter\u00E9 reprezentovaly 70 chov\u016F prasat. Kompletn\u00ED in vitro citlivost A. pleuropneumoniae byla zji\u0161t\u011Bna ke kombinaci amoxicilinu s kyselinou klavulanovou, tiamulinu, potencovan\u00E9mu sulfonamidu (co-trimoxazol) a k n\u00E1sleduj\u00EDc\u00EDm antibiotik\u016Fm s indika\u010Dn\u00EDm omezen\u00EDm: ceftiofur, cefchinom a enrofloxacin. N\u00EDzk\u00E1 prevalence rezistentn\u00EDch izol\u00E1t\u016F A. pleuropneumoniae (1,2 %) byla stanovena k amoxicilinu, tilmikosinu, florfenikolu a flumechinu. Nejvy\u0161\u0161\u00ED procento rezistentn\u00EDch A. pleuropneumoniae bylo zji\u0161t\u011Bno k tetracyklinu u 20,7 % izol\u00E1t\u016F." . . . "3"^^ . "336563" . . "Ku\u010Derov\u00E1, Zde\u0148ka" . "Efektivn\u00ED terapie aktinobacilov\u00E9 pleuropneumoniae antibiotiky je komplikov\u00E1na n\u00EDzkou \u00FArovn\u00ED imunity prasat, neuspokojivou \u00FArovn\u00ED zoohygieny a rezistenc\u00ED A. pleuropneumoniae k antibiotik\u016Fm. Kvantitativn\u00ED \u00FArove\u0148 rezistence A. pleuropneumoniae k antibiotik\u016Fm byla v roce 2008 vy\u0161et\u0159ena dilu\u010Dn\u00ED mikrometodou celkem u 82 izol\u00E1t\u016F, kter\u00E9 reprezentovaly 70 chov\u016F prasat. Kompletn\u00ED in vitro citlivost A. pleuropneumoniae byla zji\u0161t\u011Bna ke kombinaci amoxicilinu s kyselinou klavulanovou, tiamulinu, potencovan\u00E9mu sulfonamidu (co-trimoxazol) a k n\u00E1sleduj\u00EDc\u00EDm antibiotik\u016Fm s indika\u010Dn\u00EDm omezen\u00EDm: ceftiofur, cefchinom a enrofloxacin. N\u00EDzk\u00E1 prevalence rezistentn\u00EDch izol\u00E1t\u016F A. pleuropneumoniae (1,2 %) byla stanovena k amoxicilinu, tilmikosinu, florfenikolu a flumechinu. Nejvy\u0161\u0161\u00ED procento rezistentn\u00EDch A. pleuropneumoniae bylo zji\u0161t\u011Bno k tetracyklinu u 20,7 % izol\u00E1t\u016F."@cs . . .